Adding immune oncology drug to chemotherapy improves response in subset of breast cancer patients

Adding immune oncology drug to chemotherapy improves response in subset of breast cancer patients

In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and...
read more